Brand new data concludes that peppermint oil enhances the central nervous system according to a University of Mississippi study. According to researchers at the University of Mississippi, the nose-brain pathway is a likely option for medication delivery, because it bypasses the brain blockers. The main aim of the research was to analyze the effectiveness associated with peppermint essential oil for maximizing the actual bioavailability by intra-nasally administering neurotrophins, which is found to be similar to nerve growth factor (NGF).
While this may not be super important to the average consumer, it does however further the healthful and natural healing properties of peppermint essential oil. Peppermint oil is already used in countless nasal and sinus remedies and medications. One of the primary active ingredients in most of these products, such as Vicks, is menthol, which is a derivative of peppermint oil.The homeopathic product, SINUS HELP by Aromafloria: INHALATION BEADS 2.5 OZ BLEND OF EUCALYPTUS, PEPPERMINT, LEMONGRASS
The study further analyzes the levels of peppermint essential oil delivered by means of NGF via bovine olfactory epithelium were initially researched by employing in vitro Franz diffusion cells. The trans-olfactory epithelial electrical level of resistance (TEER) initially assessed the actual permeability condition of the bovine olfactory epithelium. The particular bioavailability connected with intranasally administered formulations in rats was initially examined by means of brain microdialysis in male rats. Peppermint oil concentrations of 0.05, 0.1 in addition to 0.5% v/v improved the actual in vitro of NGF by 5, 7 and 8 times. In vivo scientific tests utilizing brain microdialysis in test subjects established that intranasal treatment of NGF formulation together with 0.5% PO boosted bioavailability by 8 times when compared with subjects given NGF exclusively.
S.R.K. Vaka along with other researchers determined that, “The bioavailability of NGF in the brain could be enhanced by intranasal administration of peppermint oil.” Vaka along with colleagues published their research in Pharmazie (Enhancement of nose-brain delivery of therapeutic agents pertaining to the treatment of neurodegenerative diseases choosing peppermint oil. Pharmazie, 2010;65(9):690-692).
Additional information can be obtained by contacting S.N. Murthy, University of Mississippi, School Pharmacy, Dept. of Pharmaceutical, Faser Hall 113, University, MS 38677, USA.
The publisher of Pharmazie may be contacted at: Govi-Verlag Pharmazeutischer Verlag GmbH, Pharmazeutisccarl Mannich Str 26, D-65760 Eschborn, Germany.
Written by Brenne Meirowitz, BA, MA, MS